Nootropil

Indications:

Adults

symptomatic treatment of psychoorganic syndrome, in particular in elderly patients, accompanied by memory loss, dizziness, decreased concentration and activity, mood changes, behavioral disorders, gait disturbances (these symptoms may be early signs of age-related diseases such as Alzheimer’s disease and senile dementia of the Alzheimer’s type);
treatment of dizziness and associated balance disorders, with the exception of vasomotor and psychogenic dizziness;
treatment of cortical myoclonus (as monotherapy or in combination therapy);
prevention of sickle cell vaso-occlusive crisis.

Children

treatment of dyslexia (in combination therapy);
prevention of sickle cell vaso-occlusive crisis.

30 tablets

800 mg